Medical Care Technologies, Inc. Develops Cellular-Based Tele-Health Suite(TM)

BEIJING--(Marketwire - February 08, 2010) - Medical Care Technologies Inc. (OTCBB: MDCE) today announced that the company has begun development of a secure Cellular-Based Tele-Health Suite™ that enables users to easily transmit vital signs data via the cellular network, to healthcare professionals utilizing the Medsuite™ application. Tele-Health Suite™ is a provision of healthcare services using telecommunication technology to provide healthcare solutions over a geographic distance. Cellular access to Tele-Health Suite™ allows patients to keep their health regime intact, while being mobile at the same time. According to statistics, China’s mobile phone usage has been accelerating at a rapid rate in recent years. The nation hit the 400 million subscriber mark in February 2006; it then took 16 months to top the 500 million mark in June 2007 and another 12 months to reach the 600 million mark. Currently, China has over 700 million mobile phone users in its cellular network.

As the global healthcare market slowly changes from a traditional healthcare system to a more modern electronic healthcare system, that utilizes technology through increased usage of electronic health systems like Tele-Health Suite™, we will see limited need for the hospitalization and physical movement of patients as well as enriched health system service coverage. Tele-Health Suite™ will ultimately decrease hospital visits, thereby decreasing the overall cost of healthcare expenditure. Ning Wu, president of Medical Care Technologies, stated, “We are of the belief that Telehealth through cellular networks is going to be an important component of the modern healthcare system and will decrease pressure on the existing healthcare infrastructure. We think the Chinese market will witness substantial growth in the near future as a result of an increasing population, increase in life expectancy, increasing per capita income, and the substantial increase in Internet and cellular phone penetration in China.”

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (www.medicaretech.com) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, and consumers -- in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov and the company’s website at www.medicaretech.com

Safe Harbor Statement

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE’s products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE’s products and services, ability to deploy MDCE’s services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC’s assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC’s designees in order to close the acquisition. Accounting for the anticipated cancellation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of its common stock issued and outstanding upon the closing of the acquisition.